SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MRK: Merck & Co., Inc. -- Ignore unavailable to you. Want to Upgrade?

To: marginnayan who wrote (9)11/16/2004 6:57:10 PM
From: brian h  Respond to of 22
 
"""""MRK will not lower its dividend regardless of the litigation outcome and believes its current product liability insurance of $630 million will be more than sufficient to cover the potential litigation cost."""""

Thanks. That explains why MRK share price went up the last two days.

BH



To: marginnayan who wrote (9)11/16/2004 10:49:08 PM
From: Investor2  Read Replies (1) | Respond to of 22
 
When does MRK go ex-dividend?

Thanks,

I2


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News